Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,602 | 6,530 | 6,261 | 3,691 | -1,509 |
| Depreciation Amortization | 51 | 32 | 21 | 11 | 19 |
| Income taxes - deferred | -3,048 | -3,051 | -3,104 | -3,539 | N/A |
| Accounts receivable | -1,251 | 286 | 1,109 | 970 | -459 |
| Other Working Capital | -4,809 | -3,145 | -1,106 | 378 | -1,295 |
| Other Operating Activity | 1,768 | 105 | -844 | -836 | 2,361 |
| Operating Cash Flow | $-688 | $758 | $2,337 | $675 | $-883 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 361 | 361 | 0 | 0 | -812 |
| Investing Cash Flow | $361 | $361 | $0 | $0 | $-812 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 83 | 83 | 73 | 0 | 673 |
| Common Stock Repurchased | -740 | -360 | -206 | 0 | -458 |
| Other Financing Activity | 1,710 | 484 | 346 | 0 | 0 |
| Financing Cash Flow | $1,053 | $206 | $213 | $0 | $215 |
| Beginning Cash Position | 2,471 | 2,471 | 2,471 | 2,471 | 3,950 |
| End Cash Position | 3,197 | 3,796 | 5,021 | 3,145 | 2,471 |
| Net Cash Flow | $726 | $1,325 | $2,550 | $675 | $-1,480 |
| Free Cash Flow | |||||
| Operating Cash Flow | -688 | 758 | 2,337 | 675 | -883 |
| Free Cash Flow | -688 | 758 | 2,337 | 675 | -883 |